Conditions: Healthy
Keywords: pharmacokinetic eletriptan Korean crossover
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 16
Healthy volunteers: yes

Brief summary:
The hypothesis of this study is that Korean subjects have similar Pharmacokinetics (PK) characteristics to those seen in other populations.

Detailed description:

Arms:
arm 1: 1 X 20 mg eletriptan arm 2: 1 X 40 mg eletriptan arm 3: 2 X 40 mg eletriptan arm 4: 1 X 40 mg tablet given 2 hr after initial 1 X 40 mg tablet dose

Interventions: intervention 1: Eletriptan commercial tablet intervention 2: Eletriptan commercial tablet intervention 3: Eletriptan commercial tablet intervention 4: Eletriptan commercial tablet
Intervention descriptions: intervention 1: 20 mg tablet, single dose intervention 2: 40 mg tablet, single dose of 1 X 40 mg intervention 3: 40 mg tablet, single dose of 2 X 40 mg intervention 4: 40 mg tablet, 1 X 40 mg given two times: the second 2 hours after the first

Protocol document: